文献速递膀胱癌与上尿路尿路上皮癌泌尿系感染

膀胱癌膀胱内灌注卡介苗治疗后卡介苗感染的临床表现

Clinical presentation of bacille Calmette-Guérin (BCG) infections after BCG instillation therapy.
PubMed 文献 · BJU Int · 2022-08-30

基于芬兰癌症登记处和芬兰国家传染病登记处1996至2016年数据,识别100例灌注后卡介苗感染患者,其中39例(39%)为全身性感染、61例(61%)为泌尿生殖道感染;全身性感染多在末次灌注后迅速出现,5例(13%)潜伏≥1年;泌尿生殖道感染表现更异质,12例(20%)为晚期感染。

要点

  • 100例卡介苗感染中全身性39例(39%)、泌尿生殖道61例(61%)。
  • 全身性感染5例(13%)在末次灌注后≥1年才出现。
  • 泌尿生殖道感染12例(20%)为晚期感染。

核心结论

  • 本研究证实存在早期与晚期感染类型,尤其在全身性感染中;但晚期感染似乎比既往描述的更少见。
  • 泌尿外科医生应意识到,即使患者在卡介苗方案结束后数年出现症状,仍可能存在晚期卡介苗感染。

研究设计与样本

  • 利用芬兰癌症登记处和芬兰国家传染病登记处,识别1996至2016年间有灌注后卡介苗感染病史的患者。
  • 将感染分为全身性(非泌尿生殖系统)和泌尿生殖道感染,计算末次灌注至感染出现的时间间隔,间隔≥1年定义为晚期感染。

主要发现

  • 共识别100例卡介苗感染患者,全身性感染39例(39%),泌尿生殖道感染61例(61%)。
  • 全身性感染多数在末次灌注后迅速出现,5例(13%)在潜伏≥1年后出现。
  • 泌尿生殖道感染表现更异质,12例(20%)为晚期感染。

关键数值与推荐

  • 感染分类:全身性感染为感染累及非泌尿生殖系统,泌尿生殖道感染为感染累及泌尿生殖道。
  • 晚期感染定义为末次卡介苗灌注至感染出现的时间间隔≥1年。

临床怎么用

  • 作者指出,泌尿外科医生应意识到即使患者在卡介苗方案结束后数年出现症状,仍可能存在晚期卡介苗感染。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the timing of the clinical presentation of various types of bacille Calmette-Guérin (BCG) infections in a Finnish population of patients with bladder cancer treated with BCG instillation therapy. PATIENTS AND METHODS: We identified patients with a history of post-instillation BCG infection from 1996 to 2016 using the Finnish Cancer Registry and the Finnish National Infectious Diseases Registry. We categorised infections as systemic if the infection was found in the non-urogenital system and genitourinary (GU) if the infection affected the urogenital tract. We calculated the time interval between the last BCG instillation and the presentation of the infection. The infection was considered late if the time interval was ≥1 year. RESULTS: A total of 100 patients with BCG infection were identified during the study period. In all, 39 (39%) infections presented as systemic and 61 (61%) were in the GU tract. The majority of the systemic infections presented rapidly after the last instillation, while five (13%) presented after a latency of ≥1 year. The presentation of GU infections was more heterogeneous, with 12 (20%) presenting as late infections. CONCLUSION: This study confirms the concept of early and late infection types, especially among systemic infections. However, late infections appeared to be rarer than previously described. Urologists should be aware of the possibility of late BCG infection if patients develop symptoms even several years after the BCG regimen.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Nurminen P, Ettala O, Uusitalo-Seppälä R, et al. Clinical presentation of bacille Calmette-Guérin (BCG) infections after BCG instillation therapy. BJU Int. 2022. PMID: 35962611. doi:10.1111/bju.15870

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。